P.5.052 Early benefit of interferon β-1b inneuropsychiatric abnormalities in multiple sclerosis

Autor:	R. Munteanu, A. Ocneanu, F. Cristea, R. Nitulescu, D. Constantin, N. Popa, A. Tirca, A. Chirtes, C.A. Sirbu
Rok vydání:	2005
Předmět:	Pharmacology Psychiatry and Mental health Interferon β 1b Neurology business.industry Multiple sclerosis Immunology Medicine Pharmacology (medical) Neurology (clinical) business medicine.disease Biological Psychiatry
Zdroj:	European Neuropsychopharmacology. 15:S229-S230
ISSN:	0924-977X
DOI:	10.1016/s0924-977x(05)80454-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::abdbe7df9435ab29e74010d883a43ff3 https://doi.org/10.1016/s0924-977x(05)80454-7 Zobrazit plný text záznamu Full Text from ScienceDirect